Ceftazidime in pharma franchise in Odisha

Ceftazidime in PCD pharma franchise in Panaji

Ceftazidime in top pharma company in Hubli-Dharwad

Ceftazidime in pcd pharma supplier in Bhubaneswar

Ceftazidime in phama franchise company in India
Ceftazidime in phama distributor in Mysore

Home/Products /ceftazidime-1gm-injection

Dimezeft 1GM Injection

Composition : Ceftazidime (1gm)

Dosage Form : Injection

Packaging Type : Vial + Water

Packaging : 1

Price : ₹238/-

Dimezeft 1GM Injection contains Ceftazidime, a third-generation cephalosporin antibiotic widely recognized for its broad-spectrum antibacterial activity. It is particularly effective against a variety of gram-negative and gram-positive bacteria, including Pseudomonas aeruginosa, making it an essential choice for treating severe and complicated bacterial infections.

This injection works by inhibiting bacterial cell wall synthesis, which leads to the death of the bacteria. It is commonly used in hospital settings to manage life-threatening infections such as pneumonia, urinary tract infections (UTIs), septicemia, intra-abdominal infections, skin and soft tissue infections, and bone and joint infections.

Dimezeft 1GM Injection is administered via intravenous or intramuscular routes under the supervision of a healthcare professional. It is a reliable solution for critically ill patients or those with compromised immunity, ensuring swift bacterial eradication and recovery. Its robust efficacy and safety profile make it a preferred choice in critical care settings.

Read More

About the Product

Dimezeft 1GM Injection contains Ceftazidime, a third-generation cephalosporin antibiotic widely recognized for its broad-spectrum antibacterial activity. It is particularly effective against a variety of gram-negative and gram-positive bacteria, including Pseudomonas aeruginosa, making it an essential choice for treating severe and complicated bacterial infections.

This injection works by inhibiting bacterial cell wall synthesis, which leads to the death of the bacteria. It is commonly used in hospital settings to manage life-threatening infections such as pneumonia, urinary tract infections (UTIs), septicemia, intra-abdominal infections, skin and soft tissue infections, and bone and joint infections.

Dimezeft 1GM Injection is administered via intravenous or intramuscular routes under the supervision of a healthcare professional. It is a reliable solution for critically ill patients or those with compromised immunity, ensuring swift bacterial eradication and recovery. Its robust efficacy and safety profile make it a preferred choice in critical care settings.

Common side effects include nausea, diarrhea, pain or redness at the injection site, or mild allergic reactions. Severe reactions like anaphylaxis are rare but require immediate medical attention.

Used for severe bacterial infections, including pneumonia, septicemia, UTIs, and infections of the skin, bones, joints, and abdomen.

This medication should be administered only under medical supervision. Follow the prescribed dosage and complete the treatment course to prevent antibiotic resistance.

Store below 25°C, protected from light and moisture. Use reconstituted solutions promptly as advised by a healthcare provider.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation